{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T15:15:41Z","timestamp":1789830941283,"version":"4.0.1"},"reference-count":252,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.cbi.2021.109574","type":"journal-article","created":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T02:15:58Z","timestamp":1625278558000},"page":"109574","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"special_numbering":"C","title":["Interactions of the antioxidant enzymes NAD(P)H: Quinone oxidoreductase 1 (NQO1) and NRH: Quinone oxidoreductase 2 (NQO2) with pharmacological agents, endogenous biochemicals and environmental contaminants"],"prefix":"10.1016","volume":"345","author":[{"given":"Md Harunur","family":"Rashid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5922-1081","authenticated-orcid":false,"given":"Dinesh","family":"Babu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8317-947X","authenticated-orcid":false,"given":"Arno G.","family":"Siraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2021.109574_bib1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2174\/138527281801140121123046","article-title":"Quinone methide bioactivation pathway: contribution to toxicity and\/or cytoprotection?","volume":"18","author":"Bolton","year":"2014","journal-title":"Curr. Org. Chem."},{"key":"10.1016\/j.cbi.2021.109574_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.2174\/1389200023337388","article-title":"The metabolism and toxicity of quinones, quinonimines, quinone methides, and quinonethioethers","volume":"3","author":"Monks","year":"2002","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.cbi.2021.109574_bib3","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1021\/tx9902082","article-title":"Role of quinones in toxicology","volume":"13","author":"Bolton","year":"2000","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2021.109574_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1021\/acs.chemrestox.6b00256","article-title":"formation and biological targets of quinones: cytotoxic versus cytoprotective effects","volume":"30","author":"Bolton","year":"2017","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2021.109574_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.freeradbiomed.2019.04.026","article-title":"Reaction of quinones with proteins: kinetics of adduct formation, effects on enzymatic activity and protein structure, and potential reversibility of modifications","volume":"137","author":"Shu","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2021.109574_bib6","first-page":"188","volume":"8","author":"Klaassen","year":"2008","journal-title":"Casarett and Doull\u2019s Toxicology: The Basic Science of Poisons"},{"key":"10.1016\/j.cbi.2021.109574_bib7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0076-6879(90)86122-C","article-title":"Purification, properties, and function","volume":"186","author":"Lind","year":"1990","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.cbi.2021.109574_bib8","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180459","article-title":"NAD(P)H quinone oxidoreductase (NQO1): an enzyme which needs just enough mobility, in just the right places","volume":"39","author":"Pey","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.cbi.2021.109574_bib9","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1073\/pnas.89.6.2394","article-title":"Rapid detection of inducers of enzymes that protect against carcinogens","volume":"89","author":"Prochaska","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.cbi.2021.109574_bib10","first-page":"525","article-title":"NAD(P)H:quinone oxidoreductase1 (DT-diaphorase): expression, regulation, and role in cancer","volume":"6","author":"Joseph","year":"1994","journal-title":"Oncology Research"},{"key":"10.1016\/j.cbi.2021.109574_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1289\/ehp.908813","article-title":"Cellular responses to oxidative stress: the [Ah] gene battery as a paradigm","volume":"88","author":"Nebert","year":"1990","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.cbi.2021.109574_bib12","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1016\/S0021-9258(20)64358-7","article-title":"Transcriptional regulation of the rat NAD(P)H:quinone oxidoreductase gene. Identification of regulatory elements controlling basal level expression and inducible expression by planar aromatic compounds and phenolic antioxidants","volume":"266","author":"Favreau","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2021.109574_bib13","doi-asserted-by":"crossref","first-page":"101950","DOI":"10.1016\/j.redox.2021.101950","article-title":"The diverse functionality of NQO1 and its roles in redox control","volume":"41","author":"Ross","year":"2021","journal-title":"Redox Biology"},{"key":"10.1016\/j.cbi.2021.109574_bib14","first-page":"1899","article-title":"Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family- Extensive polymorphism at the","volume":"6","author":"Jaiswal","year":"1990","journal-title":"NQO2 gene locus on chromosome"},{"key":"10.1016\/j.cbi.2021.109574_bib15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/1479-7364-2-5-329","article-title":"Update of the NAD(P)H:Quinone oxidoreductase (NQO)gene family","volume":"2","author":"Vasiliou","year":"2006","journal-title":"Hum. Genom."},{"key":"10.1016\/j.cbi.2021.109574_bib16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0009-2797(00)00200-3","article-title":"NRH:quinone oxidoreductase2 (NQO2)","volume":"129","author":"Long","year":"2000","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2021.109574_bib17","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/S0006-2952(01)00615-3","article-title":"Comparative pharmacological studies of melatonin receptors: mt1, mt2 and mt3\/qr2. tissue distribution of mt3\/qr2","volume":"61","author":"Nosjean","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib18","doi-asserted-by":"crossref","first-page":"8846","DOI":"10.1073\/pnas.92.19.8846","article-title":"The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction","volume":"92","author":"Li","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.cbi.2021.109574_bib19","doi-asserted-by":"crossref","first-page":"9881","DOI":"10.1021\/bi990799v","article-title":"Crystal structure of human quinone reductase type 2, a metalloflavoprotein","volume":"38","author":"Foster","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2021.109574_bib20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0891-5849(00)00299-9","article-title":"Structures of mammalian cytosolic quinone reductases","volume":"29","author":"Foster","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2021.109574_bib21","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/abbi.1997.0344","article-title":"Catalytic properties of NAD(P)H: quinone oxidoreductase-2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase","volume":"347","author":"Wu","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cbi.2021.109574_bib22","doi-asserted-by":"crossref","first-page":"7714","DOI":"10.1021\/jm050730n","article-title":"Binding of the anticancer prodrug CB1954 to the activating enzyme NQO2 revealed by the crystal structure of their complex","volume":"48","author":"AbuKhader","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2021.109574_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cbic.201100085","article-title":"Mechanism-based inhibition of quinone reductase 2 (NQO2). Selectivity for NQO2 over NQO1 and structural basis for flavoprotein inhibition","volume":"12","author":"Dufour","year":"2011","journal-title":"Chembiochem"},{"key":"10.1016\/j.cbi.2021.109574_bib24","doi-asserted-by":"crossref","first-page":"11417","DOI":"10.1021\/bi049162o","article-title":"Crystal structure of quinone reductase 2 in complex with resveratrol","volume":"43","author":"Buryanovskyy","year":"2004","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2021.109574_bib25","doi-asserted-by":"crossref","first-page":"609","DOI":"10.5483\/BMBRep.2015.48.11.190","article-title":"Implications of NQO1 in cancer therapy","volume":"48","author":"Oh","year":"2015","journal-title":"BMB reports"},{"key":"10.1016\/j.cbi.2021.109574_bib26","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.bbrc.2004.08.174","article-title":"Identification and purification of resveratrol targeting proteins using immobilized resveratrol affinity chromatography","volume":"323","author":"Wang","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cbi.2021.109574_bib27","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/0003-9861(75)90200-3","article-title":"Studies on the reaction mechanism of DT diaphorase: action of dead-end inhibitors and effects of phospholipids","volume":"169","author":"Hollander","year":"1975","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cbi.2021.109574_bib28","doi-asserted-by":"crossref","first-page":"15135","DOI":"10.1021\/bi011324i","article-title":"Characterization of a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1 by biochemical, X-ray crystallographic, and mass spectrometric approaches","volume":"40","author":"Winski","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2021.109574_bib29","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0026-895X(24)12864-7","article-title":"Differential gene expression of NAD(P)H:quinone oxidoreductase and NRH:quinone oxidoreductase in human hepatocellular and biliary tissue","volume":"61","author":"Strassburg","year":"2002","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib30","doi-asserted-by":"crossref","first-page":"7624","DOI":"10.1073\/pnas.96.14.7624","article-title":"Benzene, NQO1, and genetic susceptibility to cancer","volume":"96","author":"Smith","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1016\/j.cbi.2021.109574_bib31","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0009-2797(00)00199-X","article-title":"NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms","volume":"129","author":"Ross","year":"2000","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2021.109574_bib32","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00125817-200203000-00003","article-title":"NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review","volume":"4","author":"Nebert","year":"2002","journal-title":"Genet. Med."},{"key":"10.1016\/j.cbi.2021.109574_bib33","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0891-5849(00)00306-3","article-title":"Regulation of genes encoding NAD(P)H:quinone oxidoreductases","volume":"29","author":"Jaiswal","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2021.109574_bib34","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0891-5849(00)00308-7","article-title":"Structure-function studies of DT-diaphorase (NQO1) and NRH: quinone oxidoreductase (NQO2)","volume":"29","author":"Chen","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2021.109574_bib35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.cbi.2005.03.018","article-title":"Functions and distribution of NQO1 in human bone marrow: potential clues to benzene toxicity","volume":"153\u2013154","author":"Ross","year":"2005","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2021.109574_bib36","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.bcp.2011.12.017","article-title":"NAD(P)H:Quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones","volume":"83","author":"Siegel","year":"2012","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib37","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1081\/DMR-200033465","article-title":"Quinone reductases multitasking in the metabolic world","volume":"36","author":"Ross","year":"2004","journal-title":"Drug Metabol. Rev."},{"key":"10.1016\/j.cbi.2021.109574_bib38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0083-6729(07)00005-2","article-title":"Quinone oxidoreductases and vitamin K metabolism","volume":"78","author":"Gong","year":"2008","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.cbi.2021.109574_bib39","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.abb.2010.03.019","article-title":"NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector","volume":"501","author":"Dinkova-Kostova","year":"2010","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cbi.2021.109574_bib40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cbi.2005.03.019","article-title":"Quinone oxidoreductases in protection against myelogenous hyperplasia and benzene toxicity","volume":"153\u2013154","author":"Iskander","year":"2005","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2021.109574_bib41","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3389\/fphys.2017.00595","article-title":"Functions of NQO1 in cellular protection and CoQ10 metabolism and its potential role as a redox sensitive molecular switch","volume":"8","author":"Ross","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.cbi.2021.109574_bib42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12012-011-9136-9","article-title":"NAD(P)H:Quinone oxidoreductase 1 and its potential protective role in cardiovascular diseases and related conditions","volume":"12","author":"Zhu","year":"2012","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.cbi.2021.109574_bib43","first-page":"231","article-title":"Contrasting cytotoxic mechanisms of similar antitumour diaziridinylbenzoquinones","volume":"8","author":"Butler","year":"1990","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.cbi.2021.109574_bib44","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0026-895X(25)08965-5","article-title":"Relationship between DT-diaphorase mediated metabolism of a series of aziridinylbenzoquinones and DNA damage and cytotoxicity","volume":"42","author":"Gibson","year":"1992","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib45","first-page":"7483","article-title":"Metabolism of mitomycin C by DT-diaphorase: role in mitomycin C-induced DNA damage and cytotoxicity in human colon carcinoma cells","volume":"50","author":"Siegel","year":"1990","journal-title":"Canc. Res."},{"key":"10.1016\/j.cbi.2021.109574_bib46","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/jnci\/91.22.1940","article-title":"DT-diaphorase expression and tumor cell sensitivity to 17-allylamino, 17-demethoxygeldanamycin, an inhibitor of heat shock protein 90","volume":"91","author":"Kelland","year":"1999","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.cbi.2021.109574_bib47","doi-asserted-by":"crossref","first-page":"10006","DOI":"10.1158\/0008-5472.CAN-05-2029","article-title":"Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:quinone oxidoreductase 1: role of 17-AAG hydroquinone in heat shock protein 90 inhibition","volume":"65","author":"Guo","year":"2005","journal-title":"Canc. Res."},{"key":"10.1016\/j.cbi.2021.109574_bib48","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1124\/mol.106.025643","article-title":"The bioreduction of a series of benzoquinone ansamycins by NAD(P)H:quinone oxidoreductase 1 to more potent heat shock protein 90 inhibitors, the hydroquinone ansamycins","volume":"70","author":"Guo","year":"2006","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib49","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1124\/dmd.108.022004","article-title":"Enzymatic reduction and glutathione conjugation of benzoquinone ansamycin Hsp90 inhibitors: relevance for toxicity and mechanism of action","volume":"36","author":"Guo","year":"2008","journal-title":"Drug Metabol. Dispos."},{"key":"10.1016\/j.cbi.2021.109574_bib50","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1016\/0006-2952(88)90335-8","article-title":"A new cytotoxic, DNA interstrand crosslinking agent, 5-(aziridin-1-yl)-4-hydroxylamino-2-nitrobenzamide, is formed from 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by a nitroreductase enzyme in walker carcinoma cells","volume":"37","author":"Knox","year":"1988","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib51","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/0006-2952(92)90671-5","article-title":"The bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954)\u2014I: purification and properties of a nitroreductase enzyme from Escherichia coli\u2014a potential enzyme for antibody-directed enzyme prodrug therapy (ADEPT)","volume":"44","author":"Anlezark","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib52","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1016\/0006-2952(92)90672-6","article-title":"The bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB1954)\u2014II: a comparison of an Escherichia coli","volume":"44","author":"Knox","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib53","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.1158\/0008-5472.CAN-11-3135","article-title":"An NQO1 substrate with potent antitumor activity that selectively kills by PARP1-induced programmed necrosis","volume":"72","author":"Huang","year":"2012","journal-title":"Canc. Res."},{"key":"10.1016\/j.cbi.2021.109574_bib54","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1021\/acs.accounts.5b00365","article-title":"Deoxynyboquinones as NQO1-activated cancer therapeutics","volume":"48","author":"Parkinson","year":"2015","journal-title":"Accounts Chem. Res."},{"key":"10.1016\/j.cbi.2021.109574_bib55","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/0005-2728(70)90220-3","article-title":"One-electron transfer reactions in biochemical systems. V. One-electron-transfer reactions in biochemical systems. V. Difference in the mechanism of quinone reduction by the NADH dehydrogenase and the NAD(P)H dehydrogenase (DT-diaphorase)","volume":"216","author":"Iyanagi","year":"1970","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2021.109574_bib56","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/0006-2952(95)02014-4","article-title":"Induction of DT-diaphorase by doxorubicin and combination therapy with mitomycin C in vitro","volume":"50","author":"Begleiter","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib57","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.yjmcc.2018.10.001","article-title":"Augmentation of NAD + levels by enzymatic action of NAD(P)H quinone oxidoreductase 1 attenuates adriamycin-induced cardiac dysfunction in mice","volume":"124","author":"Khadka","year":"2018","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.cbi.2021.109574_bib58","doi-asserted-by":"crossref","first-page":"7438","DOI":"10.1021\/acs.biochem.5b00884","article-title":"Binding of DNA-intercalating agents to oxidized and reduced quinone reductase 2","volume":"54","author":"Leung","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2021.109574_bib59","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.bmcl.2015.01.057","article-title":"Synthesis and evaluation of (\u00b1)-dunnione and its ortho-quinone analogues as substrates for NAD(P)H:quinone oxidoreductase 1 (NQO1)","volume":"25","author":"Bian","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.cbi.2021.109574_bib60","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1080\/10715762.2018.1475732","article-title":"Dunnione protects against experimental cisplatin induced nephrotoxicity by modulating NQO1 and NAD+ levels","volume":"52","author":"Ahmad","year":"2018","journal-title":"Free radical research"},{"key":"10.1016\/j.cbi.2021.109574_bib61","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.3390\/molecules24203697","article-title":"Antimalarial properties of dunnione derivatives as NQO2 substrates","volume":"24","author":"Chhour","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2021.109574_bib62","first-page":"199","article-title":"The role of NAD(P)H: quinone reductase (EC 1.6.99.2, DTdiaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent EO9","volume":"3","author":"Walton","year":"1991","journal-title":"Canc. Commun."},{"key":"10.1016\/j.cbi.2021.109574_bib63","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0006-2952(96)00521-7","article-title":"Bioreductive activation of a series of analogues of 5-aziridinyl-3-hydroxymethyl-1-methyl-2-[1H-indole-4, 7-dione] prop-beta-en-alpha-ol (EO9) by human DT-diaphorase","volume":"52","author":"Phillips","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib64","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1054\/bjoc.2001.2056","article-title":"A novel strategy for NQO1 (NAD(P)H:quinone oxidoreductase, EC 1.6.99.2) mediated therapy of bladder cancer based on the pharmacological properties of EO9","volume":"85","author":"Choudry","year":"2001","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.cbi.2021.109574_bib65","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0006-2952(97)00661-8","article-title":"Reduction of the indoloquinone anticancer drug EO9 by purified DT-diaphorase: a detailed kinetic study and analysis of metabolites","volume":"56","author":"Bailey","year":"1998","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib66","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1021\/cb4005832","article-title":"Efficient NQO1 substrates are potent and selective anticancer agents","author":"Parkinson","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.cbi.2021.109574_bib67","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/0006-2952(79)90348-4","article-title":"\u03b2-lapachone enhancement of lipid peroxidation and superoxide anion and hydrogen peroxide formation by Sarcoma 180 ascites tumor cells","volume":"28","author":"Docampo","year":"1979","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib68","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1006\/excr.2001.5234","article-title":"\u03b2-Lapachone-Induced apoptosis in human prostate cancer cells: involvement of NQO1\/xip3","volume":"267","author":"Planchon","year":"2001","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.cbi.2021.109574_bib69","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/S0006-2952(01)00631-1","article-title":"Relationship between NAD(P)H: quinone oxidoreductase 1 (NQO1) levels in a series of stably transfected cell lines and susceptibility to antitumor quinones","volume":"61","author":"Winski","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib70","doi-asserted-by":"crossref","first-page":"8413","DOI":"10.1073\/pnas.91.18.8413","article-title":"NAD(P)H:quinone oxidoreductase1 (DT diaphorase) specifically prevents the formation of benzo[a]pyrene quinone-DNA adducts generated by cytochrome P4501A1 and P450 reductase","volume":"91","author":"Joseph","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.cbi.2021.109574_bib71","first-page":"5638","article-title":"Role of NADPH:cytochrome c reductase and DT-diaphorase in the biotransformation of mitomycin C1","author":"Keyes","year":"1984","journal-title":"Canc. Res."},{"key":"10.1016\/j.cbi.2021.109574_bib72","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0021-9258(17)43551-4","article-title":"Reductive activation of mitomycin C and mitomycin C metabolites catalyzed by NADPH-cytochrome P-450 reductase and xanthine oxidase","volume":"259","author":"Pan","year":"1984","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2021.109574_bib73","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11033-018-4172-1","article-title":"Expressions of some antioxidant genes in SH-SY5Y cells treated with \u03b2-lapachone, morphine and electromagnetic field","volume":"45","author":"Mahmoudinasab","year":"2018","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.cbi.2021.109574_bib74","doi-asserted-by":"crossref","first-page":"18203","DOI":"10.1074\/jbc.M117.813923","article-title":"The NQO1 bioactivated drug, \u03b2-lapachone, alters the redox state of NQO1+ pancreatic cancer cells, causing perturbation in central carbon metabolism","volume":"292","author":"Silvers","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2021.109574_bib75","first-page":"3019","article-title":"Alteration in DNA cross-linking and sequence selectivity of a series of aziridinylbenzoquinones after enzymatic reduction by","volume":"31","author":"Lee","year":"1992","journal-title":"DT-diaphorase"},{"key":"10.1016\/j.cbi.2021.109574_bib76","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1021\/bi00064a013","article-title":"Two structurally related diaziridinylbenzoquinones preferentially cross-link DNA at different sites upon reduction with DT-diaphorase","volume":"32","author":"Berardini","year":"1993","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2021.109574_bib77","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0026-895X(25)10499-9","article-title":"Nicotinamide adenine dinucleotide (phosphate): quinone oxidoreductase (DT-diaphorase) as a target for bioreductive antitumor quinones: quinone cytotoxicity and selectivity in human lung and breast cancer cell lines","volume":"48","author":"Beall","year":"1995","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib78","doi-asserted-by":"crossref","first-page":"7879","DOI":"10.1021\/bi00149a019","article-title":"Bioreductive activation of mitomycin C by DT-diaphorase","volume":"31","author":"Siegel","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2021.109574_bib79","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/S0026-895X(25)13321-X","article-title":"pH-dependent inactivation of DT-diaphorase by mitomycin C and porfiromycin","volume":"44","author":"Siegel","year":"1993","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib80","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.bcp.2006.04.029","article-title":"NRH: quinone oxidoreductase 2 (NQO2) catalyzes metabolic activation of quinones and anti-tumor drugs","volume":"72","author":"Celli","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib81","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/sj.bjc.6603414","article-title":"Reduction of mitomycin C is catalysed by human recombinant NRH:quinone oxidoreductase 2 using reduced nicotinamide adenine dinucleotide as an electron donating co-factor","volume":"95","author":"Jamieson","year":"2006","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.cbi.2021.109574_bib82","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/0360-3016(92)90495-4","article-title":"The role of human and rodent DT-diaphorase in the reductive metabolism of hypoxic cell cytotoxins","volume":"22","author":"Walton","year":"1992","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.cbi.2021.109574_bib83","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/0006-2952(96)00143-8","article-title":"Bioactivation of mitomycin antibiotics by aerobic and hypoxic Chinese hamster ovary cells overexpressing DT-diaphorase","author":"Belcourt","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib84","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/bjc.1989.67","article-title":"Deficient activation by a human cell strain leads to mitomycin resistance under aerobic but not hypoxic conditions","volume":"59","author":"Marshall","year":"1989","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.cbi.2021.109574_bib85","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/0006-2952(91)90108-H","article-title":"Studies on the mechanism of resistance to mitomycin C and porfiromycin in a human cell strain derived from a cancer-prone individual","volume":"41","author":"Marshall","year":"1991","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib86","first-page":"3083","article-title":"A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent","volume":"4","author":"Winski","year":"1998","journal-title":"Clin. Canc. Res."},{"key":"10.1016\/j.cbi.2021.109574_bib87","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1021\/jm970744w","article-title":"Indolequinone antitumor agents: reductive activation and elimination from (5-methoxy-1-methyl-4,7-dioxoindol-3-yl)methyl derivatives and hypoxia-selective cytotoxicity in vitro","volume":"41","author":"Naylor","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2021.109574_bib88","series-title":"Crosslinking Studies on the Novel Bioreductive Anti-cancer Drug RH1","first-page":"4527s","author":"Ward","year":"2000"},{"key":"10.1016\/j.cbi.2021.109574_bib89","series-title":"Dissecting the Role of Multiple Reductases in Bioactivation and Cytotoxicity of the Antitumor Agent RH1","author":"Yan","year":"2008"},{"key":"10.1016\/j.cbi.2021.109574_bib90","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1002\/mc.20199","article-title":"Targeting NAD(P)H:quinone oxidoreductase (NQO1) in pancreatic cancer","volume":"56","author":"Lewis","year":"2017","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.cbi.2021.109574_bib91","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2174\/138920007779816011","article-title":"Identification of a novel intestinal first pass metabolic pathway: NQO1 mediated quinone reduction and subsequent glucuronidation","volume":"8","author":"Hao","year":"2007","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.cbi.2021.109574_bib92","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1124\/dmd.109.031864","article-title":"Regioselective glucuronidation of tanshinone IIa after quinone reduction: identification of human UDP-glucuronosyltransferases, species differences, and interaction potential","volume":"38","author":"Wang","year":"2010","journal-title":"Drug Metabol. Dispos."},{"key":"10.1016\/j.cbi.2021.109574_bib93","article-title":"An NQO1-initiated and p53-independent apoptotic pathway determines the anti-tumor effect of tanshinone IIA against non-small cell lung cancer","volume":"7","author":"Liu","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.cbi.2021.109574_bib94","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.phymed.2016.02.022","article-title":"Tanshinone IIA protects against acetaminophen-induced hepatotoxicity via activating the Nrf2 pathway","volume":"23","author":"Wang","year":"2016","journal-title":"Phytomedicine"},{"key":"10.1016\/j.cbi.2021.109574_bib95","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/00498254.2018.1432087","article-title":"Metabolic characteristics of tanshinone I in human liver microsomes and S9 subcellular fractions","volume":"49","author":"Li","year":"2019","journal-title":"Xenobiotica"},{"key":"10.1016\/j.cbi.2021.109574_bib96","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.etap.2016.06.030","article-title":"Non-cytotoxic concentrations of acetaminophen induced mitochondrial biogenesis and antioxidant response in HepG2 cells","volume":"46","author":"Zhang","year":"2016","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib97","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1007\/s00204-014-1340-5","article-title":"The protective role of NAD(P)H:quinone oxidoreductase 1 on acetaminophen-induced liver injury is associated with prevention of adenosine triphosphate depletion and improvement of mitochondrial dysfunction","volume":"89","author":"Hwang","year":"2015","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.cbi.2021.109574_bib98","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S0006-2952(99)00248-8","article-title":"Protective effect of ethanol against AcetaminophenInduced hepatotoxicity in mice","volume":"58","author":"Lee","year":"1999","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib99","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1021\/acs.chemrestox.7b00289","article-title":"Reduction and scavenging of chemically reactive drug metabolites by NAD(P)H:quinone oxidoreductase 1 and NRH:quinone oxidoreductase 2 and variability in hepatic concentrations","volume":"31","author":"Braver-Sewradj","year":"2018","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2021.109574_bib100","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1021\/mp5004866","article-title":"NQO2 is a reactive oxygen species generating off-target for acetaminophen","volume":"11","author":"Miettinen","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.cbi.2021.109574_bib101","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1080\/00498250500342746","article-title":"Characterization of the enzymes involved in the in vitro metabolism of amrubicin hydrochloride","volume":"35","author":"Tani","year":"2005","journal-title":"Xenobiotica"},{"key":"10.1016\/j.cbi.2021.109574_bib102","first-page":"31","article-title":"C609T Polymorphism of NADPH quinone oxidoreductase 1 correlates clinical hematological toxicities in lung cancer patients treated with amrubicin","volume":"2013","author":"Nagata","year":"2013","journal-title":"Clin. Med. Insights Oncol."},{"key":"10.1016\/j.cbi.2021.109574_bib103","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0026-895X(24)12836-2","article-title":"Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1","volume":"59","author":"Siegel","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib104","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00702-014-1350-8","article-title":"Aripiprazole increases NAD(P)H\u2013quinone oxidoreductase-1 and heme oxygenase-1 in PC12 cells","volume":"122","author":"Kaneko","year":"2015","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.cbi.2021.109574_bib105","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.bcp.2009.04.016","article-title":"Antimelanoma activity of the redox dye DCPIP (2,6-dichlorophenolindophenol) is antagonized by NQO1","volume":"78","author":"Cabello","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib106","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3109\/10715762.2010.526766","article-title":"DCPIP (2,6-dichlorophenolindophenol) as a genotype-directed redox chemotherapeutic targeting NQO12 breast carcinoma","volume":"45","author":"Cabello","year":"2011","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.cbi.2021.109574_bib107","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/0076-6879(67)10059-1","volume":"10","author":"Ernster","year":"1967","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.cbi.2021.109574_bib108","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017963","article-title":"NQO1-Dependent redox cycling of idebenone: effects on cellular redox potential and energy levels","volume":"6","author":"Haefeli","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.cbi.2021.109574_bib109","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10863-014-9571-y","article-title":"Idebenone and neuroprotection: antioxidant, pro-oxidant, or electron carrier?","volume":"47","author":"Jaber","year":"2015","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.cbi.2021.109574_bib110","doi-asserted-by":"crossref","first-page":"4609","DOI":"10.1523\/JNEUROSCI.1632-17.2020","article-title":"Idebenone has distinct effects on mitochondrial respiration in cortical astrocytes compared to cortical neurons due to differential NQO1 activity","volume":"40","author":"Jaber","year":"2020","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cbi.2021.109574_bib111","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.redox.2015.01.009","article-title":"Border between natural product and drug: comparison of the related benzoquinones idebenone and coenzyme Q10","volume":"4","author":"Gueven","year":"2015","journal-title":"Redox Biology"},{"key":"10.1016\/j.cbi.2021.109574_bib112","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.freeradbiomed.2019.11.030","article-title":"The ying and yang of idebenone: not too little, not too much - cell death in NQO1 deficient cells and the mouse retina","volume":"152","author":"Varricchio","year":"2020","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2021.109574_bib113","doi-asserted-by":"crossref","first-page":"40485","DOI":"10.1074\/jbc.M607704200","article-title":"Menadione-induced reactive oxygen species generation via redox cycling promotes apoptosis of murine pancreatic acinar cells","volume":"281","author":"Criddle","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2021.109574_bib114","doi-asserted-by":"crossref","first-page":"46131","DOI":"10.1074\/jbc.M208675200","article-title":"Disruption of dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2) leads to myeloid hyperplasia of bone marrow and decreased sensitivity to menadione toxicity","volume":"277","author":"Long","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2021.109574_bib115","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1124\/dmd.105.007286","article-title":"Induction of detoxifying enzymes in rodent white adipose tissue by aryl hydrocarbon receptor agonists and antioxidants","volume":"34","author":"Yoshinari","year":"2006","journal-title":"Drug Metabol. Dispos."},{"key":"10.1016\/j.cbi.2021.109574_bib116","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.3109\/10715762.2011.605788","article-title":"Insights into the redox cycle of human quinone reductase 2","volume":"45","author":"Reybier","year":"2011","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.cbi.2021.109574_bib117","doi-asserted-by":"crossref","first-page":"4602","DOI":"10.3390\/ijms20184602","article-title":"Kinetics of flavoenzyme-catalyzed reduction of tirapazamine derivatives: implications for their prooxidant cytotoxicity","volume":"20","author":"Nemeikaite-Ceniene","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2021.109574_bib118","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/0360-3016(94)90291-7","article-title":"The role of DT-diaphorase in determining the sensitivity of human tumor cells to tirapazamine (SR 4233)","volume":"29","author":"Patterson","year":"1994","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.cbi.2021.109574_bib119","author":"Phillips"},{"key":"10.1016\/j.cbi.2021.109574_bib120","first-page":"571","article-title":"Methamphetamine-induced dopaminergic neurotoxicity is regulated by quinone formation-related molecules","volume":"20","author":"Miyazaki","year":"2006","journal-title":"FASEB (Fed. Am. Soc. Exp. Biol.) J."},{"key":"10.1016\/j.cbi.2021.109574_bib121","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.phrs.2008.03.004","article-title":"Bromocriptine activates NQO1 via Nrf2-PI3K\/Akt signaling: novel cytoprotective mechanism against oxidative damage","volume":"57","author":"Lim","year":"2008","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.cbi.2021.109574_bib122","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1073\/pnas.93.6.2528","article-title":"The role of DT-diaphorase in the maintenance of the reduced antioxidant form of coenzyme Q in membrane systems","volume":"93","author":"Beyer","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.cbi.2021.109574_bib123","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/10715760290021270","article-title":"Coenzyme Q cytoprotective mechanisms for mitochondrial complex I cytopathies involves NAD(P)H: quinone oxidoreductase 1 (NQO1)","volume":"36","author":"Chan","year":"2002","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.cbi.2021.109574_bib124","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.brainres.2006.01.068","article-title":"Coenzyme Q (1) depletes NAD(P)H and impairs recycling of ascorbate in astrocytes","volume":"1078","author":"Dragan","year":"2006","journal-title":"Brain Res."},{"key":"10.1016\/j.cbi.2021.109574_bib125","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cbi.2005.01.002","article-title":"Quinone reductase 2 substrate specificity and inhibition pharmacology","volume":"151","author":"Boutin","year":"2005","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2021.109574_bib126","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1093\/carcin\/bgt246","article-title":"Reduced formation of depurinating estrogen-DNA adducts by sulforaphane or KEAP1 disruption in human mammary epithelial MCF-10A cells","volume":"34","author":"Yang","year":"2013","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cbi.2021.109574_bib127","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1016\/j.freeradbiomed.2007.07.021","article-title":"Evidence from ESI-MS for NQO1-catalyzed reduction of estrogen ortho-quinones","volume":"43","author":"Gaikwad","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2021.109574_bib128","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.freeradbiomed.2008.10.029","article-title":"Evidence for NQO2-mediated reduction of the carcinogenic estrogen ortho-quinones","volume":"46","author":"Gaikwad","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2021.109574_bib129","first-page":"833","article-title":"Control of cellular redox status and upregulation of quinone reductase NQO1 via Nrf2 activation by alpha-lipoic acid in human leukemia HL-60 cells","volume":"33","author":"Elangovan","year":"2008","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.cbi.2021.109574_bib130","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1124\/mol.52.2.300","article-title":"The reduction of alpha-tocopherol quinone by human NAD(P)H: quinone oxidoreductase: the role of alpha-tocopherol hydroquinone as a cellular antioxidant","volume":"52","author":"Siegel","year":"1997","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib131","first-page":"2869","article-title":"\u03b3-Tocotrienol controls proliferation, modulates expression of cell cycle regulatory proteins and up-regulates quinone reductase NQO2 in MCF-7 breast cancer cells","volume":"30","author":"Hsieh","year":"2010","journal-title":"Anticancer Res."},{"key":"10.1016\/j.cbi.2021.109574_bib132","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jnutbio.2009.10.010","article-title":"\u03b1-Tocopherol is an effective phase II enzyme inducer: protective effects on acrolein-induced oxidative stress and mitochondrial dysfunction in human retinal pigment epithelial cells","volume":"21","author":"Feng","year":"2010","journal-title":"JNB (J. Nutr. Biochem.)"},{"key":"10.1016\/j.cbi.2021.109574_bib133","doi-asserted-by":"crossref","first-page":"103249","DOI":"10.1016\/j.etap.2019.103249","article-title":"Effects of the organochlorinep,p\u2019-DDT on MCF-7 cells: investigating metabolic and immune modulatory transcriptomic changes","volume":"72","author":"Thompson","year":"2019","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib134","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1590\/S1984-82502016000200007","article-title":"Direct effect of p,p'-DDT on mice liver","volume":"52","author":"Arroyo-Salgado","year":"2016","journal-title":"Brazilian Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.cbi.2021.109574_bib135","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.taap.2019.02.006","article-title":"PCB 126 induces monocyte\/macrophage polarization and inflammation through AhR and NF-\u03baB pathways","volume":"367","author":"Wang","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib136","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cbi.2013.12.005","article-title":"Nrf2\/ARE pathway activation, HO-1 and NQO1 induction by polychlorinated biphenyl quinone is associated with reactive oxygen species and PI3K\/AKT signaling","volume":"209","author":"Li","year":"2014","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2021.109574_bib137","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.abb.2013.06.001","article-title":"The aryl hydrocarbon receptor interacts with nuclear factor erythroid 2-related factor 2 to mediate induction of NAD(P)H:quinoneoxidoreductase 1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin","volume":"537","author":"Wang","year":"2013","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cbi.2021.109574_bib138","doi-asserted-by":"crossref","first-page":"14502","DOI":"10.1016\/S0021-9258(17)36651-6","article-title":"Human NAD(P)H:quinone oxidoreductase2. Gene structure, activity, and tissue-specific expression","volume":"269","author":"Jaiswal","year":"1994","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2021.109574_bib139","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0003-9861(82)90202-8","article-title":"DT-diaphorase as a quinone reductase: a cellular control device against semiquinone and superoxide radical formation","volume":"216","author":"Lind","year":"1982","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.cbi.2021.109574_bib140","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1074\/jbc.270.3.1198","article-title":"Redox potential, steady-state, and rapid reaction studies","volume":"270","author":"Tedeschi","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2021.109574_bib141","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0076-6879(04)82009-3","article-title":"Structure and mechanism of NAD[P]H: quinone acceptor oxidoreductases (NQO)","volume":"382","author":"Bianchet","year":"2004","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.cbi.2021.109574_bib142","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1073\/pnas.97.7.3177","article-title":"Structures of recombinant human and mouse NAD(P)H:Quinone oxidoreductases: species comparison and structural changes with substrate binding and release","volume":"97","author":"Faig","year":"2000","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.cbi.2021.109574_bib143","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF00689803","article-title":"DT-diaphorase in activation and detoxification of quinones. Bioreductive activation of mitomycin C","volume":"12","author":"Ross","year":"1993","journal-title":"Canc. Metastasis Rev."},{"key":"10.1016\/j.cbi.2021.109574_bib144","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0006-2952(95)00223-5","article-title":"Role of NAD(P)H: quinone oxidoreductase (DT-diaphorase) in cytotoxicity and induction of DNA damage by streptonigrin","volume":"51","author":"Beall","year":"1996","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib145","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1074\/jbc.275.8.5416","article-title":"NAD(P)H:Quinone oxidoreductase activity is the principal determinant of betalapachone cytotoxicity","volume":"275","author":"Pink","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2021.109574_bib146","first-page":"2356","article-title":"Preferential activation of mitomycin C to cytotoxic metabolites by hypoxic tumor cells","volume":"40","author":"Kennedy","year":"1980","journal-title":"Canc. Res."},{"key":"10.1016\/j.cbi.2021.109574_bib147","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1124\/mol.110.070086","article-title":"A mechanistic and structural analysis of the inhibition of the 90-kDa heat shock protein by the benzoquinone and hydroquinone ansamycins","volume":"79","author":"Reigan","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib148","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.cbi.2010.04.006","article-title":"Old and new inhibitors of quinone reductase 2","volume":"186","author":"Ferry","year":"2010","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2021.109574_bib149","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/0891-5849(89)90087-7","article-title":"Mechanism of bioreductive activation: the example of diaziquone (AZQ)","volume":"6","author":"Gutierrez","year":"1985","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2021.109574_bib150","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0163-7258(87)90105-7","article-title":"Metabolism and reactions of quinoid anticancer agents","volume":"35","author":"Powis","year":"1987","journal-title":"Pharmacol. Therapeut."},{"key":"10.1016\/j.cbi.2021.109574_bib151","first-page":"7293","article-title":"Metabolism of diaziquone by NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase): role in diaziquone-induced DNA damage and cytotoxicity in human colon carcinoma cells","volume":"50","author":"Siegel","year":"1990","journal-title":"Canc. Res."},{"key":"10.1016\/j.cbi.2021.109574_bib152","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1379\/1466-1268(2001)006<0105:GTPOAC>2.0.CO;2","article-title":"Geldanamycin: the prototype of a class of antitumor drugs targeting the heat shock protein 90 family of molecular chaperones","volume":"6","author":"Ochel","year":"2001","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.cbi.2021.109574_bib153","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0006-2952(92)90033-F","article-title":"Identification of novel reduced pyridinium derivatives as synthetic co-factors for the enzyme DT diaphorase (NAD(P)Hdehydrogenase (quinone), EC 1.6.99.2)","volume":"44","author":"Friedlos","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib154","first-page":"195","article-title":"The bioactivation of CB 1954 and its use as a prodrug in antibody-directed enzyme prodrug therapy (ADEPT), Cancer and Metastasis","volume":"12","author":"Knox","year":"1993","journal-title":"Review"},{"key":"10.1016\/j.cbi.2021.109574_bib155","first-page":"4179","article-title":"Bioactivation of 5-(Aziridine-1-yl)-2,4-dinitrobenzamide (CB1954) by human NADPH quinone oxidoreductase 2: a novel cosubstrate-mediated antitumor prodrug therapy","volume":"60","author":"Knox","year":"2000","journal-title":"Canc. Res."},{"key":"10.1016\/j.cbi.2021.109574_bib156","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1021\/ja01478a049","article-title":"The structure of nybomycin","volume":"83","author":"Rinehart","year":"1961","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.cbi.2021.109574_bib157","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10557-016-6711-0","article-title":"Anthracycline chemotherapy and cardiotoxicity","volume":"31","author":"McGowan","year":"2017","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.cbi.2021.109574_bib158","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0026-895X(25)12453-X","article-title":"Anthracycline antibiotic augmentation of microsomal electron transport and free radical formation","volume":"13","author":"Bachur","year":"1977","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib159","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/0006-2952(87)90164-X","article-title":"Adriamycin-stimulated hydroxyl radical formation in human breast tumor cells","volume":"36","author":"Sinha","year":"1987","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib160","doi-asserted-by":"crossref","first-page":"11293","DOI":"10.1021\/bi971475e","article-title":"Endothelial nitric oxide synthase-dependent superoxide generation from adriamycin","volume":"36","author":"Vasquez-Vivar","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2021.109574_bib161","first-page":"1929","article-title":"Nitric oxide synthases catalyze the activation of redox cycling and bioreductive anticancer agents","volume":"59","author":"Garner","year":"1999","journal-title":"Canc. Res."},{"key":"10.1016\/j.cbi.2021.109574_bib162","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/15216540252774829","article-title":"Human heart cytosolic reductases and anthracycline cardiotoxicity","volume":"52","author":"Mordente","year":"2001","journal-title":"International Union of Biochemistry and Molecular Biology-Life"},{"key":"10.1016\/j.cbi.2021.109574_bib163","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3727\/096504003108748294","article-title":"Differential ability of cytostatics from anthraquinone group to generate free radicals in three enzymatic systems: NADH dehydrogenase, NADPH cytochromeP450 reductase, and xanthine oxidase","volume":"13","author":"Paw\u0142owska","year":"2003","journal-title":"Oncology Research"},{"key":"10.1016\/j.cbi.2021.109574_bib164","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/sj.bjc.6602639","article-title":"The role of bioreductive activation of doxorubicin in cytotoxic activity against leukaemia HL60-sensitive cell line and its multidrug-resistant sublines","volume":"93","author":"Kostrzewa-Nowak","year":"2005","journal-title":"Br. J. Canc."},{"key":"10.1016\/j.cbi.2021.109574_bib165","doi-asserted-by":"crossref","unstructured":"B. K. Shinha, Free radicals in anticancer drug pharmacology, Chem. Biol. Interact., 69 (1089) 293 \u2013 317. doi:10.1016\/0009-2797(89)90117-8.","DOI":"10.1016\/0009-2797(89)90117-8"},{"key":"10.1016\/j.cbi.2021.109574_bib166","first-page":"2872","article-title":"Activity of quinine alkylating agents in quinine resistant cells","volume":"50","author":"Begleiter","year":"1990","journal-title":"Canc. Res."},{"key":"10.1016\/j.cbi.2021.109574_bib167","first-page":"H989","article-title":"Adriamycin-induced myocardial dysfunction in vitro is mediated by free radicals","volume":"261","author":"Lee","year":"1991","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.cbi.2021.109574_bib168","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/S0891-5849(97)00025-7","article-title":"Analyses of the molecular mechanism of adriamycininduced cardiotoxicity","volume":"23","author":"Gille","year":"1997","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2021.109574_bib169","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/0031-6989(85)90113-4","article-title":"Might adriamycinol contribute to adriamycin-induced cardiotoxicity?","volume":"17","author":"Del Tacca","year":"1985","journal-title":"Pharmacol. Res. Commun."},{"key":"10.1016\/j.cbi.2021.109574_bib170","series-title":"Proceedings of the National Academy of Sciences of the United States of America","first-page":"3585","article-title":"Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol","volume":"85","author":"Olson","year":"1988"},{"key":"10.1016\/j.cbi.2021.109574_bib171","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1124\/jpet.113.206805","article-title":"A correlation between cytotoxicity and reductase-mediated metabolism in cell lines treated with doxorubicin and daunorubicin","volume":"347","author":"Bains","year":"2013","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.cbi.2021.109574_bib172","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.1111\/bph.12995","article-title":"Protective effect of 23-hydroxybetulinic acid on doxorubicin-induced cardiotoxicity: a correlation with the inhibition of carbonyl reductase-mediated metabolism","volume":"172","author":"Zhou","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib173","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/hep.23723","article-title":"Carbonyl reductase 1 as a novel target of (\u2212)-epigallocatechin gallate against hepatocellular carcinoma","volume":"52","author":"Huang","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.cbi.2021.109574_bib174","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ejmech.2012.03.039","article-title":"On the search for potential anti-Trypanosoma cruzi drugs: synthesis and biological evaluation of 2-hydroxy-3-methylamino and 1,2,3-triazolic naphthoquinoidal compounds obtained by click chemistry reactions","volume":"52","author":"da Silva Junior","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2021.109574_bib175","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00001813-199806000-00011","article-title":"Effects of 1,2-naphthoquinones on human tumor cell growth and lack of cross-resistance with other anticancer agents","volume":"9","author":"Dolan","year":"1998","journal-title":"Anti Canc. Drugs"},{"key":"10.1016\/j.cbi.2021.109574_bib176","series-title":"Indoloquinone Compounds","first-page":"5079257","author":"Speckamp","year":"1992"},{"key":"10.1016\/j.cbi.2021.109574_bib177","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0959-8049(05)80434-4","article-title":"A novel bioreductive alktlating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical models","volume":"29A","author":"Hendriks","year":"1993","journal-title":"Eur. J. Canc."},{"key":"10.1016\/j.cbi.2021.109574_bib178","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3109\/10715769609149919","article-title":"The autoxidation of the reduced forms of EO9","volume":"25","author":"Butler","year":"1996","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.cbi.2021.109574_bib179","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/jnci\/88.5.259","article-title":"Reductase enzyme expression across the National Cancer Institute Tumor cell line panel: correlation with sensitivity to mitomycin C and EO9","volume":"88","author":"Fitzsimmons","year":"1996","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.cbi.2021.109574_bib180","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ejmech.2012.12.048","article-title":"Cytotoxicity of lapachol, \u03b2-lapachone and related synthetic 1,4-naphthoquinones against oesophageal cancer cells","volume":"62","author":"Sunassee","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.cbi.2021.109574_bib181","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1124\/mol.65.5.1238","article-title":"NAD(P)H:quinone oxidoreductase 1: role as a superoxide scavenger","volume":"65","author":"Siegel","year":"2004","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib182","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/s12012-007-9001-z","article-title":"The highly expressed and inducible endogenous NAD(P)H:quinone oxidoreductase 1 in cardiovascular cells acts as a potential superoxide scavenger","volume":"7","author":"Zhu","year":"2007","journal-title":"Cardiovasc. Toxicol."},{"key":"10.1016\/j.cbi.2021.109574_bib183","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/BF03007863","article-title":"Pulmonary toxicity of antineoplastic agents: anaesthetic and postoperative implications","volume":"30","author":"Klein","year":"1983","journal-title":"Can. Anaesth. Soc. J."},{"key":"10.1016\/j.cbi.2021.109574_bib184","author":"Porfiromycin"},{"key":"10.1016\/j.cbi.2021.109574_bib185","author":"Porfiromycin"},{"key":"10.1016\/j.cbi.2021.109574_bib186","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1124\/jpet.104.081380","article-title":"RH1 induces cellular damage in an NAD(P)H:quinone oxidoreductase 1-dependent manner: relationship between DNA cross-linking, cell cycle perturbations, and apoptosis","volume":"313","author":"Dehn","year":"2005","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.cbi.2021.109574_bib187","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.radonc.2003.12.008","article-title":"Cytotoxicity of the bioreductive agent RH1 and its lack of interaction with radiation","volume":"70","author":"Kim","year":"2004","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.cbi.2021.109574_bib188","doi-asserted-by":"crossref","first-page":"10770","DOI":"10.1021\/bi000885r","article-title":"Sigmatropic reactions of the aziridinyl semiquinone species. Why aziridinyl benzoquinones are metabolically more stable than aziridinyl indoloquinones","volume":"39","author":"Xing","year":"2000","journal-title":"Biochemistry"},{"key":"10.1016\/j.cbi.2021.109574_bib189","doi-asserted-by":"crossref","first-page":"16418","DOI":"10.1021\/ja207835w","article-title":"Total synthesis of (\u00b1)-Streptonigrin: de novo construction of a pentasubstituted pyridine using ring-closing metathesis","author":"Donohoe","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.cbi.2021.109574_bib190","first-page":"219","article-title":"The mechanism of the degradation of DNA by streptonigrin","volume":"54","author":"Cone","year":"1976","journal-title":"Can. J. Biochem. Physiol."},{"key":"10.1016\/j.cbi.2021.109574_bib191","doi-asserted-by":"crossref","first-page":"13621","DOI":"10.3390\/ijms131013621","article-title":"Tanshinones: sources, pharmacokinetics and anti-cancer activities","volume":"13","author":"Zhang","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cbi.2021.109574_bib192","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3109\/03602532.2011.602688","article-title":"Oxidant stress, mitochondria, and cell death mechanisms in drug-induced liver injury: lessons learned from acetaminophen hepatotoxicity","volume":"44","author":"Jaeschke","year":"2012","journal-title":"Drug Metabol. Rev."},{"key":"10.1016\/j.cbi.2021.109574_bib193","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.redox.2016.10.001","article-title":"Oxidative stress during acetaminophen hepatotoxicity: sources, pathophysiological role and therapeutic potential","volume":"10","author":"Du","year":"2016","journal-title":"Redox Biology"},{"key":"10.1016\/j.cbi.2021.109574_bib194","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1073\/pnas.81.5.1327","article-title":"N-Acetylp-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen","volume":"81","author":"Dahlin","year":"1984","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.cbi.2021.109574_bib195","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0378-4274(93)90073-7","article-title":"Role of lipid peroxidation in acetaminopheninduced hepatotoxicity: comparison with carbon tetrachloride","volume":"66","author":"Kamiyama","year":"1993","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.cbi.2021.109574_bib196","first-page":"5","article-title":"The role of anthracyclines in small cell lung cancer","volume":"1","author":"L\u00f3pez-Gonz\u00e1lez","year":"2013","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.cbi.2021.109574_bib197","doi-asserted-by":"crossref","first-page":"18999","DOI":"10.1038\/srep18999","article-title":"Amrubicin for relapsed small-cell lung cancer: a systematic review and meta-analysis of 803 patients","volume":"6","author":"Horita","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cbi.2021.109574_bib198","doi-asserted-by":"crossref","first-page":"5401","DOI":"10.1200\/JCO.2008.18.1974","article-title":"Randomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: north Japan lung cancer study group trial 0402","volume":"26","author":"Inoue","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cbi.2021.109574_bib199","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1200\/JCO.2010.29.8851","article-title":"Randomized phase II trial of single-agent amrubicin or topotecan as second-line treatment in patients with small-cell lung cancer sensitive to first-line platinum-based chemotherapy","volume":"29","author":"Jotte","year":"2011","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.cbi.2021.109574_bib200","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0022-3565(25)10600-9","article-title":"7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity","volume":"274","author":"Kikuchi","year":"1995","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.cbi.2021.109574_bib201","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1124\/jpet.102.033175","article-title":"Aripiprazole, a novel antipsychotic, is a high-affinity partial agonist at human dopamine D2 receptors","volume":"302","author":"Burris","year":"2002","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.cbi.2021.109574_bib202","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0014-2999(02)01532-7","article-title":"The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor","volume":"441","author":"Jordan","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib203","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1007\/s11064-007-9289-x","article-title":"Protective effects of lamotrigine, aripiprazole and escitalopram on depression-induced oxidative stress in rat brain","volume":"32","author":"Eren","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.cbi.2021.109574_bib204","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.neures.2011.01.004","article-title":"Protective effects of atypical antipsychotic drugs against MPP+-induced oxidative stress in PC12 cells","volume":"69","author":"Park","year":"2011","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.cbi.2021.109574_bib205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hup.2272","article-title":"Effect of atypical antipsychotics on antioxidant enzyme activities in human erythrocytes (in vitro study)","volume":"28","author":"Miljevi\u0107","year":"2013","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.cbi.2021.109574_bib206","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.plaphy.2012.10.018","article-title":"Damage of photosynthetic apparatus in the senescing basal leaf of Arabidopsis thaliana: a plausible mechanism of inactivation of reaction center II","volume":"62","author":"Mohapatra","year":"2013","journal-title":"Plant Physiol. Biochem."},{"key":"10.1016\/j.cbi.2021.109574_bib207","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/clinchem\/32.6.1004","article-title":"Ascorbate in plasma as measured by liquid chromatography and by dichlorophenolindophenol colorimetry","volume":"32","author":"VanderJagt","year":"1986","journal-title":"Clin. Chem."},{"key":"10.1016\/j.cbi.2021.109574_bib208","first-page":"9","volume":"6","author":"CHMP","year":"2008"},{"key":"10.1016\/j.cbi.2021.109574_bib209","series-title":"Anonymous Vitamins and Hormones","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/B978-0-12-800095-3.00004-3","article-title":"Ovarian toxicity from reactive oxygen species","author":"Luderer","year":"2014"},{"key":"10.1016\/j.cbi.2021.109574_bib210","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1053\/sonc.2002.31531","article-title":"Tirapazamine: prototype for a novel class of therapeutic agents targeting tumor hypoxia","volume":"29","author":"Gandara","year":"2002","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.cbi.2021.109574_bib211","first-page":"395","article-title":"Prospects for hypoxia-activated anticancer drugs","volume":"4","author":"Denny","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.cbi.2021.109574_bib212","first-page":"111","article-title":"Isotopic labeling experiments that elucidate the mechanism of DNA strand cleavage by the hypoxia-selective antitumor agent 1,2,4-benzotriazine 1,4-di-N-oxide","volume":"22","author":"Shen","year":"2013","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2021.109574_bib213","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1021\/ja908689f","article-title":"Characterization of radicals formed following enzymatic reduction of 3-substituted analogues of the hypoxia-selective cytotoxin 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine)","volume":"132","author":"Shinde","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.cbi.2021.109574_bib214","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1021\/acs.chemrestox.6b00133","article-title":"Radical chemistry and cytotoxicity of bioreductive 3-substituted quinoxaline di-N-oxides","volume":"29","author":"Anderson","year":"2016","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2021.109574_bib215","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1021\/acs.chemrestox.9b00036","article-title":"Enzyme-activated generation of reactive oxygen species from heterocyclic N-oxides under aerobic and anaerobic conditions and its relevance to hypoxia-selective prodrugs","volume":"32","author":"Shen","year":"2019","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2021.109574_bib216","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1158\/0008-5472.CAN-15-1107","article-title":"Identi\ufb01cation of P450 oxidoreductase as a major determinant of sensitivity to hypoxia-activated prodrugs","volume":"75","author":"Hunter","year":"2015","journal-title":"Canc. Res."},{"key":"10.1016\/j.cbi.2021.109574_bib217","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0026-895X(25)13535-9","article-title":"Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones","volume":"14","author":"Graham","year":"1978","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.cbi.2021.109574_bib218","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1021\/jm00223a008","article-title":"Potential oxidative pathways of brain catecholamines","volume":"19","author":"Tse","year":"1976","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2021.109574_bib219","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1046\/j.1471-4159.1999.0731309.x","article-title":"Tyrosine hydroxylase is inactivated bycatechol-quinones and converted to a redox-cycling quinoprotein: possible relevance to Parkinson's disease","volume":"73","author":"Kuhn","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2021.109574_bib220","doi-asserted-by":"crossref","unstructured":"R. E. Whitehead, J. V. Ferrer, J. A. Javitch, J. B. Justice, Reaction of oxidized dopamine with endogenous cysteine residues in the human dopamine transporter, J. Neurochem.. 200176 (200) 1242\u20131251. doi:10.1046\/j.1471-4159.2001.00125.x.","DOI":"10.1046\/j.1471-4159.2001.00125.x"},{"key":"10.1016\/j.cbi.2021.109574_bib221","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/0028-3908(86)90242-X","article-title":"Occurrence and distribution of 5-S-cysteinyl derivatives of dopamine, dopa and dopac in the brains of eight mammalian species","volume":"25","author":"Fornstedt","year":"1986","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.cbi.2021.109574_bib222","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1046\/j.1471-4159.1999.0732546.x","article-title":"Peroxynitrite- and nitrite-induced oxidation of dopamine: implications for nitric oxide in dopaminergic cell loss","volume":"73","author":"LaVoie","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.cbi.2021.109574_bib223","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1523\/JNEUROSCI.19-04-01484.1999","article-title":"Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine","volume":"19","author":"LaVoie","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.cbi.2021.109574_bib224","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1006\/bioo.1998.1109","article-title":"Are reduced ubiquinones oxygen radical generators?","volume":"26","author":"Kozlov","year":"1998","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.cbi.2021.109574_bib225","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0076-6879(04)82017-2","article-title":"The role of endogenous catechol quinones in the initiation of cancer and neurodegenerative diseases","volume":"382","author":"Cavalieri","year":"2004","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.cbi.2021.109574_bib226","first-page":"63","article-title":"Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention","volume":"1766","author":"Cavalieri","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2021.109574_bib227","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1021\/tx050229y","article-title":"The greater reactivity of estradiol-3,4-quinone vs estradiol-2,3-quinone with DNA in the formation of depurinating adducts: implications for tumorinitiating activity","volume":"19","author":"Zahid","year":"2006","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2021.109574_bib228","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1093\/carcin\/23.6.1071","article-title":"Catechol ortho-quinones: the electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases","volume":"23","author":"Cavalieri","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cbi.2021.109574_bib229","doi-asserted-by":"crossref","first-page":"7945","DOI":"10.1038\/sj.onc.1204969","article-title":"Evidence that a burst of DNA depurination in SENCAR mouse skin induces errorprone repair and forms mutations in the H-ras gene","volume":"20","author":"Chakravarti","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.cbi.2021.109574_bib230","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jsbmb.2006.06.019","article-title":"Induction of A.T to G.C mutations by erroneous repair of depurinated DNA following estrogen treatment of the mammary gland of ACI rats","volume":"101","author":"Mailander","year":"2006","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.cbi.2021.109574_bib231","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1021\/tx0502645","article-title":"Mutagenic activity of 4-hydroxyestradiol, but not 2-hydroxyestradiol, in BB rat 2 embryonic cells, and the mutational spectrum of 4-hydroxyestradiol","volume":"19","author":"Zhao","year":"2006","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.cbi.2021.109574_bib232","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/biof.5520170120","article-title":"Lipoic acid: a multifunctional antioxidant","volume":"17","author":"Bast","year":"2003","journal-title":"Biofactors"},{"key":"10.1016\/j.cbi.2021.109574_bib233","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/mnfr.201200608","article-title":"Direct and indirect antioxidant properties of -lipoic acid and therapeutic potential","volume":"57","author":"Rochette","year":"2013","journal-title":"Mol. Nutr. Food Res."},{"key":"10.1016\/j.cbi.2021.109574_bib234","series-title":"Lipoic Acid, Micronutrient Information Center","year":"2019"},{"key":"10.1016\/j.cbi.2021.109574_bib235","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.bbagen.2009.07.026","article-title":"Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential","volume":"1790","author":"Shay","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cbi.2021.109574_bib236","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.mrfmmm.2004.06.041","article-title":"Chemoprevention through the Keap 1-Nrf2 signaling pathway by phase 2 enzyme inducers","volume":"555","author":"Kwak","year":"2004","journal-title":"Mutat. Res."},{"key":"10.1016\/j.cbi.2021.109574_bib237","first-page":"753","article-title":"Inhibition of lipid peroxidation by alpha-tocopherolquinone and alpha-tocopherolhydroquinone","volume":"10","author":"Bindoli","year":"1985","journal-title":"Biochem. Int."},{"key":"10.1016\/j.cbi.2021.109574_bib238","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0891-5849(95)00010-U","article-title":"Is \u03b1-tocopherol a reservoir for \u03b1-tocopheryl hydroquinone?","volume":"19","author":"Kohar","year":"1995","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.cbi.2021.109574_bib239","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1186\/s12936-017-2050-2","article-title":"Global trends in the production and use of DDT for control of malaria and other vector-borne diseases","volume":"16","author":"van den Berg","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.cbi.2021.109574_bib240","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jns.2011.03.014","article-title":"Endocrine disruptors as a threat to neurological function","volume":"305","author":"Weiss","year":"2011","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.cbi.2021.109574_bib241","doi-asserted-by":"crossref","first-page":"105229","DOI":"10.1016\/j.aquatox.2019.105229","article-title":"DDT exposure induces cell cycle arrest and apoptosis of skin fibroblasts from Indo-Pacific humpback dolphin via mitochondria dysfunction","volume":"213","author":"Yu","year":"2019","journal-title":"Aquat. Toxicol."},{"key":"10.1016\/j.cbi.2021.109574_bib242","doi-asserted-by":"crossref","unstructured":"R. A. Johnson, Microbial Arene Oxidations, Wiley Online Library. . doi:10.1002\/0471264180.or063.02.","DOI":"10.1002\/0471264180.or063.02"},{"key":"10.1016\/j.cbi.2021.109574_bib243","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/toxsci\/kfg149","article-title":"PCB 104-induced proinflammatory reactions in human vascular endothelial cells: relationship to cancer metastasis and atherogenesis","volume":"75","author":"Choi","year":"2003","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cbi.2021.109574_bib244","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jnutbio.2016.03.016","article-title":"Dioxin-like pollutants increase hepatic flavin containing monooxygenase (FMO3) expression to promote synthesis of the pro-atherogenic nutrient biomarker trimethylamine N-oxide from dietary precursors","volume":"33","author":"Petriello","year":"2016","journal-title":"JNB (J. Nutr. Biochem.)"},{"key":"10.1016\/j.cbi.2021.109574_bib245","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/toxsci\/kfx180","article-title":"PCB126 exposure increases risk for peripheral vascular diseases in a liver injury mouse model","volume":"160","author":"Wahlang","year":"2017","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.cbi.2021.109574_bib246","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.tiv.2012.04.028","article-title":"Polychlorinated biphenyl quinone metabolites lead to oxidative stress in HepG2 cells and the protective role of dihydrolipoic acid","volume":"26","author":"Liu","year":"2012","journal-title":"Toxicol. Vitro"},{"key":"10.1016\/j.cbi.2021.109574_bib247","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1289\/ehp.94102s9157","article-title":"The mechanism of dioxin toxicity: relationship to risk assessment","volume":"102","author":"Birnbaum","year":"1994","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.cbi.2021.109574_bib248","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1146\/annurev.pa.22.040182.002505","article-title":"2,3,7,8-tetrachlorodibenzo-p-dioxin and related halogenated aromatic hydrocarbons: examination of the mechanism of toxicity","volume":"22","author":"Poland","year":"1982","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.cbi.2021.109574_bib249","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/BF01964077","article-title":"A microbial metabolite of TCDD","volume":"38","author":"Philippi","year":"1982","journal-title":"Experientia"},{"key":"10.1016\/j.cbi.2021.109574_bib250","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1039\/c3ay26443b","article-title":"A new method for identification of in vitrometabolites of 2,3,7,8-TCDD with rat liver microsomes by using liquid chromatography-mass spectrometry","volume":"5","author":"Wang","year":"2013","journal-title":"Analytical Methods"},{"key":"10.1016\/j.cbi.2021.109574_bib251","series-title":"Drinking Water Criteria Document for 2,3,7,8-Tetrachlorodibenzo-P-Dioxin","author":"Basu","year":"1984"},{"key":"10.1016\/j.cbi.2021.109574_bib252","series-title":"Hazardous Materials Toxicology: Clinical Principles of Environmental Health","author":"Sullivan","year":"1992"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000927972100212X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000927972100212X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:08:54Z","timestamp":1757858934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000927972100212X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":252,"alternative-id":["S000927972100212X"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2021.109574","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interactions of the antioxidant enzymes NAD(P)H: Quinone oxidoreductase 1 (NQO1) and NRH: Quinone oxidoreductase 2 (NQO2) with pharmacological agents, endogenous biochemicals and environmental contaminants","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2021.109574","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109574"}}